CATHERINE VALLORANI: Open Payments
NPI 1275213878 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 58 payments from 12 companies in 2025. Trend: 2023 $317 · 2024 $1,108 · 2025 $1,255
Food & beverage: $1,246Education: $9
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $262 |
| QOL Medical, LLC | 11 | $217 |
| Ardelyx, Inc. | 11 | $203 |
| ABBVIE INC. | 9 | $184 |
| Janssen Biotech, Inc. | 6 | $149 |
| Madrigal Pharmaceuticals | 6 | $126 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Celltrion USA Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: DUPIXENT, Sucraid, IBSRELA, TREMFYA, REZDIFFRA, SKYRIZI, RINVOQ, CREON.
Industry payments across FL — which companies pay providers there.
